about
Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cellsDecreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis.Host defense against infections and inflammations: role of the multifunctional IL-6/IFN-beta 2 cytokine.Restrictin-P: the first member of a putative family of novel inhibitors.Recombinant interferon-beta 2 (interleukin-6) induces myeloid differentiation.Effects of interleukin-6 on the growth of normal and transformed rat liver cells in culture.
P2860
Q33661906-F2C2C61C-5232-4420-962C-2AB6E6082D6CQ36357033-C24B64BC-14AD-453D-9CE3-B4C57F810CDDQ37514453-8050C927-F7E1-4F22-A3DC-1878046F3E25Q38650083-9E6FC04D-EFB1-4A71-822B-99B5923F7AACQ41700301-3951E533-0050-4DCB-AAD7-2C612E9FC3C2Q42038243-DB1090C7-68B3-4A1D-8A59-98E839DAC466Q53518050-6A9A9754-97D8-4A48-A327-23FE806B17AD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Autocrine interferons and interferon-beta 2.
@en
type
label
Autocrine interferons and interferon-beta 2.
@en
prefLabel
Autocrine interferons and interferon-beta 2.
@en
P2093
P356
P1476
Autocrine interferons and interferon-beta 2
@en
P2093
P304
P356
10.1089/JIR.1987.7.529
P577
1987-10-01T00:00:00Z